Clinical trial · Observational
Seoul National University Pituitary Disease Cohort Study
NCT03474601CI-TRIAL-00044103SNU-PITunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the treatment and natural history of pituitary disease. We have a longstanding interest in pituitary disease including acromegaly, central diabetes insipidus, and nonfunctioning pituitary adenoma. We will continue to follow patients and recruit new patients for treatment and follow-up. Blood and pituitary tumor tissue (when available through clinical care) will be saved for future analyses related to pituitary disease.
Conditions
Conditions (8)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acromegaly | — | UNRESOLVED | — |
| Central Diabetes Insipidus | — | UNRESOLVED | — |
| Cushing's Disease | — | UNRESOLVED | — |
| Pituitary Disease | — | UNRESOLVED | — |
| Pituitary Incidentaloma | — | UNRESOLVED | — |
| Pituitary Stalk Compression Hyperprolactinaemia | — | UNRESOLVED | — |
| Pituitary Tumor | Pituitary Gland Neoplasm | ALIAS | 0.90 |
| Prolactinoma | Lactotroph Pituitary Neuroendocrine Tumor | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dynamic hormone study and Magnetic resonance imaging | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (8)
- label
- Acromegaly
- description
- Patients diagnosed with acromegaly
- interventionNames
- Other: Dynamic hormone study and Magnetic resonance imaging
- label
- Cushing's disease
- description
- Patients diagnosed with Cushing's disease
- interventionNames
- Other: Dynamic hormone study and Magnetic resonance imaging
- label
- Hyperprolactinemia/prolactinomas
- description
- Patients diagnosed with hyperprolactinemia/prolactinoma
- interventionNames
- Other: Dynamic hormone study and Magnetic resonance imaging
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects for this study will be recruited if they are: 1. Adults, male or female aged 18 years or older 2. diagnosed with pituitary diseases such as acromegaly, Cushing's disease, hyperprolactinemia, nonfunctioning pituitary adenoma, pituitary stalk lesions, central diabetes insipidus, and craniopharyngiomas Exclusion Criteria: * Patients who do not agree with the study
References
Publications (0)
Data not yet available
No reference posted for this study.